268 related articles for article (PubMed ID: 38165473)
1. COX 2-inhibitors; a thorough and updated survey into combinational therapies in cancers.
Rodrigues P; Bangali H; Hammoud A; Mustafa YF; Al-Hetty HRAK; Alkhafaji AT; Deorari MM; Al-Taee MM; Zabibah RS; Alsalamy A
Med Oncol; 2024 Jan; 41(1):41. PubMed ID: 38165473
[TBL] [Abstract][Full Text] [Related]
2. Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement.
Li S; Jiang M; Wang L; Yu S
Biomed Pharmacother; 2020 Sep; 129():110389. PubMed ID: 32540642
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis.
Gately S; Kerbel R
Prog Exp Tumor Res; 2003; 37():179-92. PubMed ID: 12795055
[TBL] [Abstract][Full Text] [Related]
4. Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance?
Choy H; Milas L
J Natl Cancer Inst; 2003 Oct; 95(19):1440-52. PubMed ID: 14519750
[TBL] [Abstract][Full Text] [Related]
5. Improvement of radiotherapy or chemoradiotherapy by targeting COX-2 enzyme.
Milas L; Mason KA; Crane CH; Liao Z; Masferrer J
Oncology (Williston Park); 2003 May; 17(5 Suppl 5):15-24. PubMed ID: 12800601
[TBL] [Abstract][Full Text] [Related]
6. The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers.
Salehifar E; Hosseinimehr SJ
Drug Discov Today; 2016 Apr; 21(4):654-62. PubMed ID: 26955911
[TBL] [Abstract][Full Text] [Related]
7. Cyclo-oxygenase-2 and its inhibition in cancer: is there a role?
Liao Z; Mason KA; Milas L
Drugs; 2007; 67(6):821-45. PubMed ID: 17428102
[TBL] [Abstract][Full Text] [Related]
8. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
9. Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy.
Sarkar FH; Adsule S; Li Y; Padhye S
Mini Rev Med Chem; 2007 Jun; 7(6):599-608. PubMed ID: 17584158
[TBL] [Abstract][Full Text] [Related]
10. Selective cyclooxygenase-2 (COX-2) inhibitors used for preventing or regressing cancer.
de Souza Pereira R
Recent Pat Anticancer Drug Discov; 2009 Jun; 4(2):157-63. PubMed ID: 19519538
[TBL] [Abstract][Full Text] [Related]
11. Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.
Kirane A; Toombs JE; Ostapoff K; Carbon JG; Zaknoen S; Braunfeld J; Schwarz RE; Burrows FJ; Brekken RA
Clin Cancer Res; 2012 Sep; 18(18):5031-42. PubMed ID: 22829202
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 in cancer: A review.
Hashemi Goradel N; Najafi M; Salehi E; Farhood B; Mortezaee K
J Cell Physiol; 2019 May; 234(5):5683-5699. PubMed ID: 30341914
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed.
Liu R; Xu KP; Tan GS
Eur J Pharmacol; 2015 Dec; 769():127-33. PubMed ID: 26548623
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 inhibition in colorectal cancer: boom or bust?
Sanborn R; Blanke CD
Semin Oncol; 2005 Feb; 32(1):69-75. PubMed ID: 15726508
[TBL] [Abstract][Full Text] [Related]
15. Current directions for COX-2 inhibition in breast cancer.
Chow LW; Loo WT; Toi M
Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S281-4. PubMed ID: 16507393
[TBL] [Abstract][Full Text] [Related]
16. Potential for combined modality therapy of cyclooxygenase inhibitors and radiation.
Saha D; Choy H
Prog Exp Tumor Res; 2003; 37():193-209. PubMed ID: 12795056
[TBL] [Abstract][Full Text] [Related]
17. Cancer and cyclooxygenase-2 (COX-2) inhibition.
Evans JF; Kargman SL
Curr Pharm Des; 2004; 10(6):627-34. PubMed ID: 14965325
[TBL] [Abstract][Full Text] [Related]
18. Molecular and Metabolomic Investigation of Celecoxib Antiproliferative Activity in Mono-and Combination Therapy against Breast Cancer Cell Models.
Bardaweel SK; Dahabiyeh LA; Akileh BM; Shalabi DD; AlHiary AK; Pawling J; Dennis JW; Rahman AMA
Anticancer Agents Med Chem; 2022; 22(8):1611-1621. PubMed ID: 34515014
[TBL] [Abstract][Full Text] [Related]
19. The role of COX-2 inhibition in breast cancer treatment and prevention.
Arun B; Goss P
Semin Oncol; 2004 Apr; 31(2 Suppl 7):22-9. PubMed ID: 15179621
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel COX-2 / CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities.
Nuvoli B; Antoniani B; Libener R; Maconi A; Sacconi A; Carosi M; Galati R
J Exp Clin Cancer Res; 2021 Aug; 40(1):257. PubMed ID: 34404424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
